Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXOR9V
|
||||
| Drug Name |
3-butyl-7-[(1E)-1-(methoxyimino)ethyl]-19-methyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-14-one
|
||||
| Synonyms |
CHEMBL403606
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H29N5O2
|
||||
| Canonical SMILES |
CCCCn1c2ccc(cc2c3c4CNC(=O)c4c5c(CCc6nn(C)cc56)c13)\\C(=N\\OC)\\C
|
||||
| InChI |
InChI=1S/C27H29N5O2/c1-5-6-11-32-22-10-7-16(15(2)30-34-4)12-18(22)24-19-13-28-27(33)25(19)23-17(26(24)32)8-9-21-20(23)14-31(3)29-21/h7,10,12,14H,5-6,8-9,11,13H2,1-4H3,(H,28,33)/b30-15+
|
||||
| InChIKey |
GYGDJIJJUWOMRC-FJEPWZHXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.